Package 80725-012-30

Brand: lunesta

Generic: eszopiclone
NDC Package

Package Facts

Identity

Package NDC 80725-012-30
Digits Only 8072501230
Product NDC 80725-012
Product ID 80725-012_4a1b20fc-a41d-41dd-a557-fa9333bb5c3b
Description

30 TABLET, COATED in 1 BOTTLE (80725-012-30)

Marketing

Marketing Status
Marketed Since 2023-08-15
Brand lunesta
Generic eszopiclone
Sample Package No

Linked Drug Pages (1)

Lunesta ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4a1b20fc-a41d-41dd-a557-fa9333bb5c3b", "openfda": {"upc": ["0380725010301", "0380725012305", "0380725011308"], "unii": ["UZX80K71OE"], "rxcui": ["485440", "485442", "485465", "540407", "540409", "540411"], "spl_set_id": ["3821f4b7-a3c8-4920-ba80-18aa96532c09"], "manufacturer_name": ["Waylis Therapeutics LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (80725-012-30)", "package_ndc": "80725-012-30", "marketing_start_date": "20230815"}], "brand_name": "Lunesta", "product_id": "80725-012_4a1b20fc-a41d-41dd-a557-fa9333bb5c3b", "dosage_form": "TABLET, COATED", "product_ndc": "80725-012", "dea_schedule": "CIV", "generic_name": "ESZOPICLONE", "labeler_name": "Waylis Therapeutics LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lunesta", "active_ingredients": [{"name": "ESZOPICLONE", "strength": "3 mg/1"}], "application_number": "NDA021476", "marketing_category": "NDA", "marketing_start_date": "20230815", "listing_expiration_date": "20261231"}